Ex­clu­sive: 10x Ge­nomics CEO touts ‘in­cred­i­ble trac­tion’ with newest launch, ship­ping over 100 spa­tial bi­ol­o­gy an­a­lyz­ers

10x Ge­nomics has seen “in­cred­i­ble trac­tion” with its newest prod­uct, Xe­ni­um, ship­ping over 100 an­a­lyz­ers since launch­ing less than a year ago, CEO Serge Sax­onov told End­points News.

The mile­stone, an­nounced Tues­day, is the lat­est sign of speedy adop­tion in re­searchers us­ing new spa­tial bi­ol­o­gy tools to peer in­side of cells. Xe­ni­um acts like a mol­e­c­u­lar mi­cro­scope, Sax­onov said, vi­su­al­iz­ing how mol­e­cules are or­ga­nized in­side a tis­sue sam­ple. Since launch­ing last De­cem­ber, 10x’s newest in­stru­ment has out­per­formed the com­pa­ny and Wall Street’s ex­pec­ta­tions.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER